欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子化合物 > 小分子抑制剂 > Ro3280

商品分类

浏览历史

S81196

Ro3280

MedMol 99%
  • 英文名:
  • 4-((9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide
  • 别名:
  • RO3280; RO-3280; RO 3280; Ro5203280; Ro-5203280; Ro 5203280.
  • CAS号:
  • 1062243-51-9
  • 分子式:
  • C27H35F2N7O3
  • 分子量:
  • 543.61
品牌货号产品规格价格(RMB)库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
MedMol S81196-1mg 99% ¥510.00元 预计交期:3-5天 0 0 0 EA 加入购物车
MedMol S81196-2mg 99% ¥900.00元 预计交期:3-5天 0 0 0 EA 加入购物车
MedMol S81196-5mg 99% ¥1300.00元 预计交期:3-5天 0 0 0 EA 加入购物车
MedMol S81196-10mg 99% ¥2100.00元 预计交期:3-5天 0 0 0 EA 加入购物车
MedMol S81196-25mg 99% ¥4000.00元 预计交期:3-5天 0 0 0 EA 加入购物车
MedMol S81196-50mg 99% ¥6000.00元 预计交期:3-5天 0 0 0 EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: Ro3280 is a potent, highly selective inhibitor of PLK1 with an IC50 and a Kd of 3 nM and 0.09 nM, respectively, and nearly has no effect on PLK2 and PLK3
  • 靶点: PLK1:0.09 nM (Kd);ALK:230 nM (Kd);CAMKK1:1100 nM (Kd);CAMKK2:87 nM (Kd);DAPK1:100 nM (Kd);DAPK3:70 nM (Kd);FER:53 nM (Kd);GAK:87 nM (Kd);MYLK:170 nM (Kd);PTK2:84 nM (Kd);PTK2B:130 nM (Kd);RPS6KA6 (KinDom.2):560 nM (Kd);TTK:51 nM (Kd)
  • 体外研究: Ro3280 (RO3280) inhibits PLK1 activity in NB4 and K562 cells, with an IC50s of 13.45 nM and 301 nM, respectively. RO3280 shows inhibitory activities against the growth of six leukemia cells, with IC50s of 186 nM, 175 nM, 74 nM, 797 nM, 120 nM and 162 nM for U937, HL60, NB4, K562, MV4-11 and CCRF cell lines, respectively. RO3280 also suppresses the growth of primary ALL and AML cells, with IC50s of 35.49-110.76 nM, and 52.80-147.50 nM, respectively. RO3280 (50 or 100 nM) induces apoptosis and cell cycle disorder in acute leukemia cells. Ro3280 shows potent activity in H82, H69, A549 lung cancer cell lines with EC50s of 6 nM, 7 nM and 82 nM. Ro3280 also inhibits several other cancer cell lines, with low concentration. RO3280 is cytotoxic to 5637 and T24 human bladder cancer cells, with IC50s of appr 100 nM.
  • 体内研究: Ro3280 (RO3280, 40 mg/kg, i.v.) inhibits 72% tumor growth in a mouse xenograft model implanted with HT-29 colorectal cancer cells, and when dosed more frequently, RO3280 completely suppresses the tumor growth. RO3280 (30 mg/kg, once every 5 days, i.p.) shows significant anti-bladder cancer activities in a nude mouse model.
  • 参考文献:
    1. Wang NN, et al. Molecular targeting of the oncoprotein PLK1 in pediatric acute myeloid leukemia: RO3280, a novel PLK1 inhibitor, induces apoptosis in leukemia cells. Int J Mol Sci. 2015 Jan 7;16(1):1266-92.
    2. Chen S, et al. Identification of novel, potent and selective inhibitors of Polo-like kinase 1. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1247-50.
    3. Zhang Z, et al. Targeted inhibition of Polo-like kinase 1 by a novel small-molecule inhibitor induces mitotic catastrophe and apoptosis in human bladder cancer cells. J Cell Mol Med. 2017 Apr;21(4):758-767.
  • 溶解性: soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 1.84 ml 9.198 ml 18.396 ml
    5 mM 0.368 ml 1.84 ml 3.679 ml
    10 mM 0.184 ml 0.92 ml 1.84 ml
    50 mM 0.037 ml 0.184 ml 0.368 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。